The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding

Pharmacotherapy

Volumn 25, Issue 3, 2005, Pages 411-425

  Whitby, Dale H ^a   Smith, Kelly M ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Kentucky   (United States)

Author keywords

Breastfeeding; Lactation; Nursing; Postpartum depression; Selective serotonin reuptake inhibitors; SSRIs; TCAs; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DESIPRAMINE; DOSULEPIN; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANTICHOLINERGIC EFFECT; BLOOD SAMPLING; BREAST FEEDING; BREAST MILK; COLIC; DIZZINESS; DRUG BIOAVAILABILITY; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HUMAN; INFANT NUTRITION; LETHARGY; MAJOR CLINICAL STUDY; MUSCLE HYPOTONIA; PUERPERAL DEPRESSION; REVIEW; SEIZURE; SIDE EFFECT; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BREAST FEEDING; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; SEROTONIN UPTAKE INHIBITORS;

EID: 14544303601     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.3.411.61597     Document Type: Review

References (80)

1. O'Hara MW, Swain AM. Rates and risk of postpartum depression; a meta-analysis. Int Rev Psychiatry 1996;8:37-54.
2. Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry 1998;59(suppl 2):34-40.
3. Miller L. Postpartum depression. JAMA 2002;287:762-5.
4. Wisner KL, Parry BL, Piontek CM. Postpartum depression. N Engl J Med 2002;347:194-9.
5. American Psychiatric Association. The diagnostic and statistical manual of mental disorders, 4th ed (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
6. O'Hara MW, Neunaber DI, Zekoski EM. A prospective study of post-partum depression: prevalence, course and predictive factors. J Abnorm Psych 1984;93:158-71.
7. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993:163:27-31.
8. Misri S, Kostaras X. Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug Safety 2002;25 (13):903-11.
9. Josefsson A, Berg G, Nordin C, Sydsjo G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand 2001;80:251-5.
10. Hodges A. Little new in Yates story on "American justice." Houston Chronical. Available from http://www.chron.com/cs/CDA/story.hts/special/ drownings/1736112. Accessed May 15, 2003.
11. Robinson B. A postpartum defense? Lawyers for Indiana woman say she was delusional from postpartum depression. Available from http://abcnews.go.com/ sections/us/DailyNews/postpartum000511.html. Accessed May 15, 2003.
12. CBC News Online Staff. Mother who killed son on subway dies of injuries. Available from http://toronto.cbc.ca/cgibin/templates/view.cgi?/news/2000/08/14/ 000814subway. Accessed May 15, 2003.
13. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000;343:118-26.
14. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk. Clin Pharmacokinet 1994;27:270-89.
15. Hale TW. Medications and mother's milk, 10th ed. Amarillo, Texas: Pharmasoft Medical, 2002.
16. Burt VK, Suir R, Altshuler L, Stowe Z, Hendrick VC, Muntean E. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001;158:1001-9.
17. Wilson JT, Brown RD, Cherek DR, et al. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 1980;5:1-66.
18. Yoshida K, Smith B, Craggs M, Kumar RC. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 1997;43:225-37.
19. Ilett KF, Lebedevs TH, Wojnar-Horton RE, et al. The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol 1992;33:635-9.
20. Buist A, Janson H. Effect of exposure to dothiepin and northiaden in breast milk on child development. Br J Psychiatry 1995;167:370-3.
21. Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991;148:1234-6.
22. Wisner KL, Perel JM. Nortriptyline treatment in breast-feeding women [letter]. Am J Psychiatry 1996;153:295.
23. Wisner KL, Perel JM, Findling RL, Hinnes RL. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharm Bull 1997;33:249-51.
24. Bader TF, Newman K. Amitriptyline in human breast milk and the nursing infant's serum. Am J Psychiatry 1980;137:117-20.
25. Brixen-Rasmussen L, Halgrener J, Jorgensen A. Amitriptyline and nortriptyline excretion in human breast milk. J Clin Psychopharmacol 1982;76:94-5.
26. Pittard WB, O'Neal W. Amitriptyline excretion in human milk. J Clin Psychopharmacol 1986;6:383-4.
27. Erickson SH, Smith GH, Heidrich F. Tricyclics and breast feeding [letter]. Am J Psychiatry 1979;136:1483.
28. Sovner R, Orsulak P. Excretion of imipramine and desipramine in human breast milk. Am J Psychiatry 1979;136:451-2.
29. Stancer HC, Reed KL. Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum. Am J Psychiatry 1986;143:1597-600.
30. Kemp J, Ilett K, Booth J, Hackett LP. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985;20:497-9.
31. Matheson I, Pande H, Alertson A. Respiratory depression caused by N-desmethyldoxepin in breast milk [letter]. Lancet 1985;2:1124.
32. Frey O, Scheidt P, von Brenndorff A. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;33:690-2.
33. Stowe ZN, Owens MJ, Landry JC, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997;154:1255-60.
34. Kristensen JH, Ilet KF, Dusci LJ, et al. Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br J Clin Pharmacol 1998;45:453-7.
35. Dodd S, Stocky A, Buist A, et al. Sertraline in paired blood plasma and breast-milk samples from nursing mothers. Hum Psychopharmacol Clin Exp 2000;15:261-4.
36. Stowe ZN, Hostetter AL, Owens MJ, et al. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry 2003;64:73-80.
37. Dodd S, Buist A, Burrows GD, Norman TR. Sertraline analysis in the plasma of breast-fed infants. Aust NZ J Psychiatry 2001;35:545-6.
38. Altshuler LL, Burt VK, McMullen M, Hendrick V. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995;56:243-5.
39. Mammen OK, Perel JM, Rudolph G, Foglia JP, Wjeeler SB. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 1997;58:100-3.
40. Wisner KL, Perel JM, Blumer J. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998;155:690-2.
41. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 2001;158:1631-7.
42. Hendrick A, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001;179:163-6.
43. Misri S, Kim J, Riggs KW, Kostaras X. Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 2000;61:828-32.
44. Öhman R, Hagg S, Carleborg L, Spigset O. Excretion of paroxetine into breast milk. J Clin Psychiatry 1999;60:519-23.
45. Stowe ZN, Cohen LS, Hosteller A, Ritchie JC, Owens MJ, Nemeroff CB. Paroxeline in human breast milk and nursing infants. Am J Psychiatry 2000;157:185-9.
46. Hendrick V, Stowe ZN, Altshuler LL, Hostetter A, Fukuchi A. Paroxeline use during breast-feeding. J Clin Psychopharmacol 2000;20(5):587-9.
47. Yoshida K, Smith B, Craggs M, Kumar RC. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998;172:175-9.
48. Hendrick V, Stowe ZN, Altshuler LL, et al. Fluoxeline and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry 2001;52:446-51.
49. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Adolescent Psych 1993;32:1253-5.
50. Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 1992;89:676-7.
51. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996;36:42-7.
52. Kristensen JH, Ilett KF, Hackett LP, Yapp P, Paech M, Begg EJ. Distribution and excretion of fluoxeline and norfluoxetine in human milk. Br J Clin Pharmacol 1999;48:521-7.
53. Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr 2001;40:681-4.
54. Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998;37:41-4.
55. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxeline [online exclusive article]. Pediatrics 1999;104:e61. Available from htlp://pediatrics.aappublications.org/cgi/content/ full/104/5/e61.
56. Wright A, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk. Br J Clin Pharmacol 1991;31:209-10.
57. Yoshida K, Smith B, Channi-Kumar R. Fluvoxamine in breastmilk and infant development. Br J Clin Pharmacol 1997;44: 210-1.
58. Piontek CM, Wisner KL, Perel JM, Peindl KS. Serum fluvoxamine levels in breastfed infants. J Clin Psychiatry 2001;62:111-13.
59. Jensen PN, Olesen OV, Bertelsen A, Linnel K. Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther Drug Monitoring 1997:19:236-9.
60. Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72(2): 184-91.
61. Rampono J, Kristensen JH, Hackett LP, Paech M, Kohan R, Ilett KF. Citalopram and demethylcitalopram in human milk; distribution, secretion and effects in breast-fed infants. J Clin Pharmacol 2000;50:263-8.
62. Schmidt K, Olesen OV, Jensen PN. Citalopram and breastfeeding: serum concentration and side effects in the infant. Biol Psychiatry 2000;47:164-5.
63. Lee A, Woo J, Ho S. Frequency of infant adverse event that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 2004;190(1):218-21.
64. Hendrick V, Smith LM, Hwang S, Altshuler LL, Haynes D. Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry 2003;64:410-12.
65. Baumann P, Larson F. The pharmacokinetics of citalopram. Rev Contemp Pharmacother 1995;6:287-95.
66. Waugh J, Goa KL. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 2003;17(5):343-62.
67. Haddad PM. Antidepressant discontinuation syndromes. Drug Safety 2001;24:183-97.
68. Beck CT. The effects of postpartum depression on maternal-infant interaction: a meta-analysis. Nursing Res 1995;44: 298-304.
69. Beck CT. The effects of postpartum depression in child development: a meta-analysis. Arch Psychiatr Nurs 1998;12:12-20.
70. Hoffbrand S, Howard L, Crawley H. Antidepressant drug treatment for postnatal depression. Cochrane Database Syst Rev 2001;2:CD002018.
71. Preskorn SH, Burke MJ. Somatic therapy for major depressive disorder: selection of an antidepressant. J Clin Psychiatry 1992;53(suppl 9):5-18.
72. Suri R, Stowe ZN, Hendrick V, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol Psychiatry 2002;52:446-51.
73. Newport DJ, Wilcox MM, Stowe ZN. Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Semin Perinatol 2001;25:177-90.
74. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breastfeeding. Am J Psychiatry 1996;153:1132-7.
75. Iqbal MM. Effects of antidepressants during pregnancy and lactation. Ann Clin Psychiatry 1999;11:237-56.
76. Nulman I, Rovert J, Stewart D, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62.
77. Spencer JP, Gonzalez LS, Barnhart DJ. Medications in the breast-feeding mother. Am Fam Physician 2001;64:119-26.
78. Lin KM, Finder E. Neuroleptic dosage for Asians. Am J Psychiatry 1983;140:490-1.
79. Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M. A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in the black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol 1996;42:713-19.
80. Dodd S, Buist A, Norman T. Antidepressants and breastfeeding: a review of the literature. Paediatr Drugs 2000;2(3): 183-92.